Protocol Ledger

NCT04288999 · Phase III · RECRUITING

Surgery Plus Chemo Versus Chemoradiotherapy Followed by Surgery Plus Chemo for Locally Recurrent Rectal Cancer

Interventional Phase III clinical trial protocol NCT04288999 sponsored by National Cancer Center Hospital East in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2019-10-01 Enrollment: 110 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT04288999
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)110 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)3 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04288999
Protocol FieldVerified Registry Value
NCT IdentifierNCT04288999
Consolidated Lead SponsorNational Cancer Center Hospital East
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment110 participants (ESTIMATED)
Registered Start Date2019-10-01
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT04288999
Hospital Research SiteLocationSite Profile
Chiba Cancer CenterChiba, JapanOpen Hospital Dossier ->
National Cancer Center Hospital EastKashiwa, JapanOpen Hospital Dossier ->
Kumamoto University HospitalKumamoto, JapanOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI